- Home
- EW vs CCEP Comparison
EW vs CCEP Comparison
Compare EW & CCEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EW | CCEP |
|---|---|---|
| Founded | 1958 | 1986 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.9B | 44.0B |
| IPO Year | 1999 | 2015 |
Fundamental Metrics
Financial Performance| Metric | EW | CCEP |
|---|---|---|
| Price | $86.13 | $104.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 6 |
| Target Price | $96.37 | ★ $104.33 |
| AVG Volume (30 Days) | ★ 3.9M | 1.8M |
| Earning Date | 04-23-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $6,067,600,000.00 | N/A |
| Revenue This Year | $13.39 | $4.86 |
| Revenue Next Year | $9.81 | $3.79 |
| P/E Ratio | $133.58 | ★ $20.93 |
| Revenue Growth | ★ 11.55 | N/A |
| 52 Week Low | $72.30 | $84.66 |
| 52 Week High | $96.29 | $110.90 |
Technical Indicators
Market Signals| Indicator | EW | CCEP |
|---|---|---|
| Relative Strength Index (RSI) | 40.64 | 60.15 |
| Support Level | $82.02 | $89.82 |
| Resistance Level | $86.49 | $110.20 |
| Average True Range (ATR) | 2.27 | 2.33 |
| MACD | -0.91 | -0.20 |
| Stochastic Oscillator | 7.28 | 53.65 |
Price Performance
Historical ComparisonAbout EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
About CCEP Coca-Cola Europacific Partners plc
CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and Southeast Asia. In 2025, CCEP sold 3.9 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume.TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.